Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
pulmonary fibrosis and chronic obstructive lung disease. The mission of our research is to uncover novel insights into the initiation and propagation of vascular diseases with the overarching goal of
-
Positions) Posting Number req27249 Department Asthma/Airway Disease Rsch Ctr Department Website Link https://airways.arizona.edu/ Location Tucson Campus Address Tucson, AZ USA Position Highlights The Asthma
-
cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex also has a robust clinical
-
development of progressive lung fibrosis. The lab uses a combination of transgenic mice, -omic technologies, and organoid models to develop and refine hypothetical mechanisms through which epithelial
-
, Lung Cancer, Pulmonary Hypertension, Pulmonary Fibrosis, or the management of liver transplant patients. Responsibilities will include supervision of medical students, residents, and fellows in the
-
-Sayer at AstraZeneca and will work have opportunity to work across the two sites. Project Overview Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal interstitial lung disease (ILD) in which
-
fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex also has a robust clinical pipeline
-
pulmonary fibrosis, progressive fibrotic ILD, and scleroderma related ILD. We are looking for a motivated individual to join our collaborative team. The job would require interacting with physicians
-
fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex also has a robust clinical
-
underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research